Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 233

1.

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Crinò L, Weder W, van Meerbeeck J, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v103-15. doi: 10.1093/annonc/mdq207. No abstract available.

2.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

D'Addario G, Früh M, Reck M, Baumann P, Klepetko W, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v116-9. doi: 10.1093/annonc/mdq189. No abstract available.

3.

Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Sørensen M, Pijls-Johannesma M, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v120-5. doi: 10.1093/annonc/mdq172. No abstract available.

4.

Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma.

Clark JI, Albain KS.

Cancer Treat Res. 2001;105:149-70. Review. No abstract available.

PMID:
11224986
5.

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).

Felip E, Stahel RA, Pavlidis N; ESMO Guidelines Task Force.

Ann Oncol. 2005;16 Suppl 1:i28-9. No abstract available.

6.

Evolution and future perspectives in the treatment of locally advanced non-small cell lung cancer.

Toschi L, Cappuzzo F, Jänne PA.

Ann Oncol. 2007 Jul;18 Suppl 9:ix150-5. Review. No abstract available.

7.

Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial.

Dillman RO, Herndon J, Seagren SL, Eaton WL Jr, Green MR.

J Natl Cancer Inst. 1996 Sep 4;88(17):1210-5.

8.

Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.

D'Addario G, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2008 May;19 Suppl 2:ii39-40. doi: 10.1093/annonc/mdn081. No abstract available.

9.

Stage IIIA-N2 NSCLC: a review of its treatment approaches and future developments.

van Meerbeeck JP, Surmont VF.

Lung Cancer. 2009 Sep;65(3):257-67. doi: 10.1016/j.lungcan.2009.02.007. Epub 2009 Mar 13. Review.

PMID:
19285751
10.

What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?

Van Meerbeeck JP, De Pauw R, Tournoy K.

Expert Rev Anticancer Ther. 2008 Feb;8(2):199-206. doi: 10.1586/14737140.8.2.199. Review.

PMID:
18279061
11.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E; ESMO Guidelines Working Group.

Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. No abstract available.

12.

Treatment of advanced (stages III and IV) non-small-cell lung cancer.

Sweeney CJ, Sandler AB.

Curr Probl Cancer. 1998 Mar-Apr;22(2):85-132. Review.

PMID:
9580849
13.

Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up.

Labianca R, Nordlinger B, Beretta GD, Brouquet A, Cervantes A; ESMO Guidelines Working Group.

Ann Oncol. 2010 May;21 Suppl 5:v70-7. doi: 10.1093/annonc/mdq168. No abstract available.

14.

Adjuvant chemotherapy in non-small cell lung cancer (NSCLC).

Felip E, Cedrés S, Peralta S, Prat A.

Ann Oncol. 2007 Jul;18 Suppl 9:ix143-6. Review. No abstract available.

15.

Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.

Lynch TJ, Bogart JA, Curran WJ Jr, DeCamp MM, Gandara DR, Goss G, Henschke CI, Jett JR, Johnson BE, Kelly KL, Le Chevalier T, Mulshine JL, Scagliotti GV, Schiller JH, Shaw A, Thatcher N, Vokes EE, Wood DE, Hart C.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):4981s-4983s. No abstract available.

16.

Combined modality therapy of non-small cell lung cancers.

Juretic A, Sobat H, Samija M.

Ann Oncol. 1999;10 Suppl 6:93-8. Review.

PMID:
10676559
17.

NCCN: Non-small cell lung cancer.

Ettinger DS, Kris MG; NCCN Non-Small Cell Lung Cancer Practice Guidelines Panel.

Cancer Control. 2001 Nov-Dec;8(6 Suppl 2):22-31. Review. No abstract available.

PMID:
11760555
18.

Non-small-cell lung cancer: multimodality approach in stage-III resectable disease.

Thomas M, Hoffknecht P, Droege C, Baisch A, Reinmuth N, Kreuter M, Lange T, Berdel WE.

Lung Cancer. 2004 Aug;45 Suppl 2:S99-105. Review.

PMID:
15552789
19.

Adjuvant therapy in completely resected non-small-cell lung cancer.

Scagliotti GV, Novello S.

Curr Oncol Rep. 2003 Jul;5(4):318-25. Review.

PMID:
12781075
20.

Combined modality treatment of locally advanced lung cancer.

Trovò MG, Gigante M, Minatel E, Gobitti C, Franchin G.

Tumori. 1998 Mar-Apr;84(2):259-69. Review.

PMID:
9620255
Items per page

Supplemental Content

Write to the Help Desk